In Vitro Diagnostic Industry in China - POCT VIII

1.1 Blood Glucose

The latest IDF Diabetes Atlas (2025) reports that diabetes affects 589 million adults (20-79 years) around the world in 2024, with over 4 in 10 unaware that they have the condition. Over 4 in 5 adults (81%) with diabetes live in low- and middle-income countries. By 2050, IDF projections show that 1 in 8 adults, approximately 853 million, will be living with diabetes, an increase of 46%. Diabetes was responsible for an estimated USD 1.015 trillion in global health expenditure in 2024. This represents a 338% increase over the past 17 years. Diabetes was responsible for an estimated USD 1.015 trillion in global health expenditure in 2024. This represents a 338% increase over the past 17 years. On average 1,760 USD are spent per person with diabetes.

Diabetes is becoming a major public health challenge of the twenty-first century, particularly in developing countries. With the steady growth of patients with type 2 diabetes, increased public awareness of the disease, and the tilt of the health insurance reimbursement policy, blood glucose testing has continued to grow at a relatively high rate in recent years. In 2024, the global market size of POCT blood glucose testing was $3.53 billion. It is expected to reach $5.81 Billion till 2034, at a CAGR is expected to be around 5.10% during the forecast period (2025-2034).

Last: In Vitro Diagnostic Industry in China - POCT VII